Isocitrate Dehydrogenase 2 Inhibitors [MoA] - N0000193614

Pharmacologic Class Information

Pharmacologic Code N0000193614
Pharmacologic Name Isocitrate Dehydrogenase 2 Inhibitors
Pharmacologic Uses
  • isocitrate dehydrogenase-2 inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Isocitrate Dehydrogenase 2 Inhibitors

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Isocitrate Dehydrogenase 2 Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
59572-705Idhifa Non-Proprietary Name: Enasidenib MesylateTablet, Film CoatedOralCelgene CorporationACTIVE
59572-710Idhifa Non-Proprietary Name: Enasidenib MesylateTablet, Film CoatedOralCelgene CorporationACTIVE